2010 The Clinical Investigators Workshop

ACCREDITATION STATEMENT
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this educational activity for a maximum of 9.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

STATEMENT OF INDEPENDENCE
As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, The Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of The Endocrine Society's Trainee and Development Core Committee (TCDCC). The commercial supporters of this activity have no influence over the selection of the faculty or specific presentations.

DISCLAIMER
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of The Endocrine Society.

LEARNING OBJECTIVES
Upon completion of this educational activity, learners will be able to:

  • Offer the highest standard of care to patients who may choose to participate in clinical trials
  • Employ new knowledge and skills to effectively design and implement new clinical research that paves the way for improvements in clinical care and maintains the highest ethical standards

TARGET AUDIENCE
This continuing medical education activity should be of substantial interest to clinical fellows engaged in advancing clinical research.

DISCLOSURE POLICY
The faculty, committee members, and staff involved in planning this CME activity are required to disclose to learners any relevant financial relationship(s) that have occurred within the last 12 months with any commercial interest(s) whose products or services are discussed in the CME content. Such relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent faculty with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments. It remains for learners to determine whether financial interests or relationships may influence the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:

  • Ronald Swerdloff, MD has been a grant recipient and consultant for Clarus, a grant recipient and consultant from EndoPharm, and a grant recipient from Solvay Pharmaceuticals, Inc (now Abbott).

The following faculty reported no relevant financial relationships:

  • Barbara Araneo, PhD
  • Andrew R. Hoffman, MD
  • James F. Hyde, PhD
  • Laurence Katznelson, MD
  • Stanley Korenman, MD
  • Hau Liu, MBA, MD, MPH
  • Ruchi Mathur, MD
  • Joy Y. Wu, MD, PhD
  • William F. Young, Jr., MD, MSc
  • Mark A. Bach, MD, PhD has received employee salary from Johnson & Johnson and has been an employee of and received stock/stock options from Merck & Co but will not discuss specific products and services.

The following Trainee and Career Development Core Committee members who planned and/or reviewed content for this activity reported relevant financial relationships:

  • None

The following Trainee and Career Development Core Committee members who planned and/or reviewed content for this activity reported no relevant financial relationships:

  • Laurence Katznelson, MD
  • Mark Lawson, PhD
  • Joy Y. Wu, MD, PhD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

CONFLICT OF INTEREST STATEMENT
The scientific content of this activity was developed by The Endocrine Society's Trainee and Career Development Core Committee (TCDCC), independent of grant support and in accordance with the ACCME's Essential Areas and Elements, inducing the Standards for Commercial Support. The commercial supporters of this meeting have no influence over topics or speakers.

POLICY ON UNLABELED/OFF-LABEL USE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such "off-label" use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grant(s) from Pfizer. Financial support was also received from the Juvenile Diabetes Research Foundation International.

METHOD OF PARTICIPATION
The estimated time to complete this activity, including review of material, is 9.75 hour(s).

This enduring material is presented in an online/computer-based format. System requirements include:

  • For Windows, Firefox 1.5 or Internet Explorer 6.0 with Flash 8 or better installed.
  • For Macintosh OS X, Safari 2.0 or Firefox 1.5 with Flash 8 or better installed.

To receive a maximum of 9.75 AMA PRA Category 1 Credit(s)™ participants should:

  • Select a session and listen to the audio and/or view the slides.
  • Complete the evaluation provided at the end of the session and click on "submit" to add the session to the learner's transcript. The transcript will appear and the learner will have the option of printing a CME certificate then or at a later time, after viewing multiple sessions.
  • Select additional sessions and proceed as directed above, to accumulate credits for participating in multiple sessions.
  • Credits awarded correspond to the length of time for each session, which varies from 0.25 to 1.0 hours

LAST REVIEW DATE: November, 2010.
ACTIVITY RELEASE DATE: November, 2010.
ACTIVITY EXPIRATION DATE: November, 2013.

For technical assistance or information, please contact 1-888-711-1138 ext.241 or 972-910-6899 (9:00 AM to 5:00 PM EST) or E-mail: multiviewMediaSupport@multiview.com.

For questions about content or obtaining CME credit, please contact The Endocrine Society at education@endo-society.org.

I have read the CME guidelines outlined.